Quantcast
Last updated on April 16, 2014 at 21:24 EDT

Annual Drug Discovery Conferences Being Held in Boston MA, Spring 2012

March 14, 2012

FARMINGTON, Conn., March 14, 2012 /PRNewswire-iReach/ — Global Information Inc. is excited to announce 4 significant Drug Discovery and Healthcare conferences scheduled for Boston, MA in the Spring of 2012.

8th Annual PEGS, Protein Engineering Summit
April 30 – May 4, 2012: Cambridge Healthtech Institute is hosting the Eighth Annual PEGS: Protein Engineering Summit in Boston, MA. This comprehensive event encompasses 12 tracks, 15 short courses, and a preconference partnering forum for showcasing early stage companies. Topics span from early stage discovery of new methods for protein expression and antibody engineering, to improved analytical techniques, and clinical results in the most promising areas of biotechnology. There is tremendous momentum and investment in biologics, and PEGS offers an unparalleled view of the field.

Additional information and Early Bird discounted rates are available at http://www.giiconference.com/chi214651-2012/

Next-Gen Kinase Inhibitors
June 4 – 6, 2012: Pioneers from across the rapidly maturing kinase inhibitors field will gather to explore the exciting question of what lies ahead at the Next-Gen Kinase Inhibitors Conference in Cambridge, MA. What is in store for the pharmaceutical industry and what new avenues are opening up for new technologies and methods as novel targets and therapeutic approaches are explored? What ground-breaking kinase indications are being discovered, and what other therapeutic areas are blossoming?

Topics to be explored include key issues around addressing resistance; selectivity versus safety; developing lead compounds; the integration of chemistry and biology; using promising techniques such as fragment and structure based design; optimizing PK and PD; and analyzing the flood of data available.

Additional information and Early Bird discounted rates are available at http://www.giiconference.com/chi214653-2012/

CHI and Bio-IT World’s 12th Annual Structure-Based Drug Design Conference
June 6 – 8, 2012: Structure-based drug design took nearly two decades of multiple, parallel technological improvements to arrive at its current mainstream position in medicinal chemistry. At the CHI and Bio-IT World’s 12th Annual Structure-Based Drug Design Conference in Cambridge, MA, an accomplished faculty of experts will bring to focus recent advancements in this evolving and dynamic field. Developments in computer graphics, high-power radiation sources, computational processing power, refinement protocols, virtual screening and crystallography were all necessary to create the environment for rapid, iterative structure-based drug discovery. Given the crisis facing the pharmaceutical industry in the translation of early stage drug discovery results, a different set of tools, concerned with algorithms and methods for developing best in class drugs that engage biological targets with kinetically optimized potency and selectivity will need to be refined.

Additional information and Early Bird discounted rates are available at http://www.giiconference.com/chi214654-2012/

Discover more biotechnology research and resources:
http://www.giiresearch.com/bio_report.shtml

About Global Information Inc. Global Information (GII) (http://www.giiresearch.com) is an information service company partnering with over 300 research companies around the world. Global Information has been in the business of distributing technical and market research for more than 25 years. Expanded from its original headquarters in Japan, Global Information now has offices in Korea, Taiwan, Singapore, Europe and the United States.

Media Contact: Jeremy Palaia of Global Information, Inc., 1-860-674-8796, Press@gii.co.jp

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

SOURCE Global Information, Inc.


Source: PR Newswire